- PROFESSOR AND SYSTEM CHAIR Thoracic Surgery
American Board of Surgery
MD, Albert Einstein College of Medicine
Columbia-Presbyterian Medical Center
Residency, Cardiothoracic Surg
Brigham and Women's Hospital, Harvard Medical School
Dr. Raja M. Flores is the Chairman for the Department of Thoracic Surgery, Steven and Ann Ames Professor in Thoracic Surgery at The Mount Sinai Medical Center.
Dr. Flores’ is a recognized leader in the field of Thoracic Surgery for his pioneering efforts in the treatment of mesothelioma. He has established VATS lobectomy, a minimally invasive approach using three small incisions, as the gold standard in the surgical treatment of lung cancer. He published two sentinel studies validating its oncological effectiveness by demonstrating equivalent survival and recurrence rates with fewer complications and shorter hospital stays when compared to standard thoracotomy. Dr. Flores implemented the current program for this procedure at Memorial Sloan-Kettering Cancer Center. He was a lead investigator in a multicenter trial of neoadjuvant alimta/cisplatin, extrapleural pneumonectomy, and high-dose radiation which is designed to improve outcomes.
Dr. Flores currently has one of the largest VATS lobectomy experiences in the world. He has published this data and has presented it at numerous national and international meetings.
Dr. Flores’ additional research interests are based on numerous past projects relating to the multimodality management of malignant pleural mesothelioma, as well as innovative surgical techniques in minimally invasive thoracic surgery for lung cancer. He has led a number of major studies, including clinical trials of neoadjuvant gemcitabine and cisplatin followed by extrapleural pneumonectomy and high dose radiation. Presently, he has received a $395,000 subaward grant from the University of Pittsburgh Department of Biomedical Informatics. Dr. Flores represents Mount Sinai Medical Center's efforts and, along with his group, contributes to the National Mesothelioma Virtual Bank which provides a wide array of well-categorized, searchable biospecimens to investigate the disease process of mesothelioma and potential therapeutic targets. Dr. Flores is the Principle Investigator of the Libby Epidemiology Research Program, a $4.8 million RO1 grant funded by the Agency for Toxic Substances and Disease Registry (ATSDR). The major goals of the research are to address questions regarding the health consequences of asbestos exposure (Libby Amphibole).
After earning an undergraduate degree in biochemistry from New York University, Dr. Flores attended the Albert Einstein College of Medicine, receiving his Medical Degree in 1992. He then spent five years at Columbia-Presbyterian Medical Center pursuing his General Surgery Internship and General Surgery Residency. He then completed a Thoracic Oncology Clinical Research Fellowship at Brigham and Women’s Hospital/Dana Faber Cancer Institute/CALGB in Boston, and his Cardiothoracic Surgery Residency at Brigham and Women’s Hospital, Harvard Medical School. He also received a Masters in Biostatistics from Columbia University. Dr. Flores is a member of numerous medical and surgical societies and serves on several editorial boards.
In the News
Dr. Flores discusses mesothelioma in the NY Daily News feature, The Daily Checkup. View the PDF
Steven and Ann Ames Professorship in Thoracic Surgery
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Flores did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 7 Room 54
1468 Madison Avenue
New York, NY 10029
1470 Madison Avenue
New York, NY 10029
- Monday 9:00am - 5:00pm
- Tuesday 9:00am - 5:00pm
- Wednesday 9:00am - 5:00pm
- Thursday 9:00am - 5:00pm
- Friday 9:00am - 5:00pm
- Access Meicare
- Blue Cross/ Blue Shield
- CIGNA - Indemnity
- CIGNA Healthcare HMO
- GHI HMO
- HIP Commercial
- HIP Medicaid
- HIP Medicare
- HealthFirst HMO Medicaid
- HealthFirst HMO Medicare
- HealthPlus, Inc.
- MetroPlus Health Plan
- MultiPlan, Inc.
- Neighborhood Health Providers, LLC
- Oxford Health Plans
- Senior Plan
- United Health Care - Mount Sinai Top Tier
- United Health Care Empire Plan
- Worker's Compensation
- Master Card
- American Express
- Personal Check
- Credit Card (Other)